Get the latest news alerts: at Twitter.
Local Tech Wire
DURHAM, N.C. – officially joins the Nasdaq on Friday with its stock trading under the symbol OXBT.
Plus, Chairman and Chief Executive Officer Chris Stern will get to ring the Nasdaq opening bell on Friday, Jan. 22.
However, Bell told a forum in San Francisco on Thursday that the company, which is focused on oxygen-based therapeutics, has bigger plans for 2010. Speaking at the OneMedForum, Bell said OxyBio plans four cosmetic product launches this year.
The new offerings include an eye cream to fight “fine line wrinkles,” a face lotion, an “improved oxygen concentrate gel” and what it calls a “perfluorocarbon skin oxygenating liquid” that uses its oxygen-based technology.
Other planned products include two veterinary offerings, one for topical wound treatment and the other being an intravenous solution for treatment of multiple problems.
The company recently executed a reverse 15-for-1 stock split.
OxyBio is focused on oxygen-based therapeutics. Its “Oxycyte in Traumatic Brain Injury” has been accepted for a Phase II clinical trial in Switzerland. The acceptance was announced Aug. 14.
OxyBio trades currently over the counter under the symbol OXBT.
